If you’ve been tracking Cosmos Health (NASDAQ: COSM), you know the price action has been a rollercoaster, but the CEO’s conviction is starting to look like a permanent "Buy" button.
📈 The Lead Story: Another Massive Buy
Just yesterday, January 14, 2026, CEO Grigorios Siokas acquired 493,495 shares at an average price of $0.4458, totaling roughly $220,000.
This isn't a one-off. Siokas has been on an absolute tear since the start of 2025:
• Total 2025/2026 Buys: Over 3.4 million shares acquired by the CEO alone.
• Current Holding: He now directly owns over 7.7 million shares.
• The Trend: 11+ open market purchases in the last 6 months with zero sales.
He’s putting his money where his mouth is. By taking shares instead of cash, he’s betting that the stock is worth significantly more than the current ~$0.45 range.
Recent Business Updates:
Beyond the insider buying, Cosmos has been active:
• Manufacturing Wins: Just signed a deal with Libytec to produce PathMuscle (muscle relaxant/pain reliever).
• Zacks Coverage: Zacks Small-Cap Research recently initiated coverage with a $4.50 price target, citing their diversified revenue base and vertical integration.
• Crypto Treasury: They are still moving forward with an Ethereum-based treasury strategy and IP tokenization.
Bottom Line: The CEO is aggressively accumulating, and analysts are pegging the "Fair Value" much higher than the current price. However, with a potential reverse split looming to stay on the Nasdaq, the volatility isn't going away anytime soon.
What do you guys think? Is Siokas just "averaging down" on a grand scale, or does he know something the market is missing?
Disclaimer: Not financial advice. Penny stocks/Micro-caps like COSM carry extreme risk.